• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    4/5/24 1:06:12 PM ET
    $ACB
    $AGS
    $AIH
    $ARDX
    Medicinal Chemicals and Botanical Products
    Health Care
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $ACB alert in real time by email

    Shares of Byrna Technologies Inc. (NASDAQ:BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

    Byrna Technologies posted quarterly sales of $16.65 million, topping market estimates of $11.49 million, according to data from Benzinga Pro. The company also said its CFO David North will retire later this year.

    Byrna Technologies shares jumped 7.1% to $14.74 on Friday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • MediaCo Holding Inc. (NASDAQ:MDIA) shares jumped 141.7% to $3.4106 after a 13D amended filing showed Standard General L.P. reported a 95.2% stake in the company as of April 1, 2024.
    • HUB Cyber Security Ltd. (NASDAQ:HUBC) shares climbed 67.7% to $1.7442 after the company announced $8 million in financing via a straight debt arrangement.
    • GCT Semiconductor Holding, Inc. (NASDAQ:GCTS) gained 51.8% to $8.69 after the company and Aramco signed an MOU to accelerate the development of the 4G and 5G ecosystem in Saudi Arabia.
    • DigiAsia Corp. (NASDAQ:FAAS) shares jumped 46% to $8.03 after falling 18% on Thursday.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) gained 37% to $3.18.
    • Destiny Tech100 Inc. (NYSE:DXYZ) gained 29% to $43.26.
    • Grindrod Shipping Holdings Ltd. (NASDAQ:GRIN) shares climbed 27.8% to $13.44 after the company announced a selective capital reduction.
    • 22nd Century Group, Inc. (NASDAQ:XXII) gained 26.4% to $1.87 after dipping 16% on Thursday. On March 28, 22nd Century reported fourth-quarter earnings and announced a stock split of 1-for-16.
    • MiNK Therapeutics, Inc. (NASDAQ:INKT) rose 26.2% to $1.6913.
    • Kazia Therapeutics Limited (NASDAQ:KZIA) rose 17% to $0.39.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) rose 16.5% to $0.1075. Sunshine Biopharma recently posted FY23 operating results.
    • SuperCom Ltd. (NASDAQ:SPCB) shares gained 16.4% to $0.2455 after jumping 19% on Thursday.
    • Envoy Medical, Inc. (NASDAQ:COCH) rose 15.5% to $6.77. Envoy Medical recently reported better-than-expected financial results.
    • Outset Medical, Inc. (NASDAQ:OM) climbed 14.2% to $2.2150.
    • Kura Sushi USA, Inc. (NASDAQ:KRUS) gained 9.8% to $114.00 following the release of second-quarter results.
    • PlayAGS, Inc. (NYSE:AGS) rose 9.7% to $9.30.
    • Greenlane Holdings, Inc. (NASDAQ:GNLN) rose 9.3% to $0.57.
    • Ardelyx, Inc. (NASDAQ:ARDX) climbed 8% to $7.74. Leerink Partners analyst Roanna Ruiz initiated coverage on Ardelyx with an Outperform rating and announced a price target of $14.
    • Yatsen Holding Limited (NYSE:YSG) gained 7.8% to $2.89.
    • Spotify Technology S.A. (NYSE:SPOT) gained 4.4% to $308.95 after Pivotal Research maintained a Buy rating on the stock and raised its price target from $330 to $390.

    Losers

    • Semantix, Inc. (NASDAQ:STIX) shares fell 34.5% to $0.57 after the company announced it will voluntarily delist from the Nasdaq Global Market.
    • noco-noco Inc. (NASDAQ:NCNC) fell 19.8% to $0.2210.
    • IM Cannabis Corp. (NASDAQ:IMCC) dipped 19.6% to $0.8601.
    • Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) fell 19.2% to $0.4131 after gaining 11% on Thursday.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) shares dipped 17.6% to $0.7250.
    • HWH International Inc. (NASDAQ:HWH) fell 17.6% to $1.8950 after jumping 46% on Thursday.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) declined 17.3% to $0.1188.
    • NewGenIvf Group Limited (NASDAQ:NIVF) shares fell 15.5% to $1.2673 after dipping 45% on Thursday.
    • Brooge Energy Limited (NASDAQ:BROG) fell 14.7% to $1.6198.
    • Tempest Therapeutics, Inc. (NASDAQ:TPST) dipped 14.4% to $3.85.
    • Ermenegildo Zegna N.V. (NYSE:ZGN) shares fell 14% to $11.99 as the company reported FY23 financial results.
    • DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) dipped 12.5% to $8.91.
    • Reliance Global Group, Inc. (NASDAQ:RELI) fell 11.7% to $0.4678 after reporting a loss for the fourth quarter.
    • LAMF Global Ventures Corp. I (NASDAQ:LGVC) fell 11.5% to $9.55.
    • Biodesix, Inc. (NASDAQ:BDSX) fell 11.2% to $1.34 after the company announced pricing of its oversubscribed and upsized underwritten offering of common stock and concurrent private placement.
    • Altice USA, Inc. (NYSE:ATUS) fell 9.9% to $2.3169 after Wells Fargo downgraded the stock from Equal-Weight to Underweight and lowered its price target from $2 to $1.
    • Aurora Cannabis Inc. (NASDAQ:ACB) declined 6.4% to $6.61.

     

    Now Read This: Netflix To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Friday

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $AGS
    $AIH
    $ARDX

    CompanyDatePrice TargetRatingAnalyst
    Kazia Therapeutics Limited
    $KZIA
    4/15/2026$25.00Buy
    Laidlaw
    Spotify Technology S.A.
    $SPOT
    4/13/2026$630.00Overweight
    Morgan Stanley
    Byrna Technologies Inc.
    $BYRN
    4/10/2026$7.50Buy → Hold
    Craig Hallum
    Envoy Medical Inc.
    $COCH
    3/31/2026$2.50Buy
    H.C. Wainwright
    Spotify Technology S.A.
    $SPOT
    3/26/2026$535.00Outperform
    Daiwa Securities
    Kura Sushi USA Inc.
    $KRUS
    3/6/2026$90.00Buy
    DA Davidson
    Biodesix Inc.
    $BDSX
    2/27/2026Mkt Perform → Outperform
    William Blair
    Spotify Technology S.A.
    $SPOT
    2/26/2026$586.00Neutral → Buy
    Arete
    More analyst ratings

    $ACB
    $AGS
    $AIH
    $ARDX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Patel Mona Chetan bought $125,000 worth of shares (312,500 units at $0.40), increasing direct ownership by 1,562% to 332,500 units (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:51:51 PM ET
    $COCH
    Industrial Specialties
    Health Care

    Interim CFO Potashnick Robert bought $85,000 worth of shares (212,500 units at $0.40) (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:49:33 PM ET
    $COCH
    Industrial Specialties
    Health Care

    $ACB
    $AGS
    $AIH
    $ARDX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Laidlaw initiated coverage on Kazia Therapeutics with a new price target

    Laidlaw initiated coverage of Kazia Therapeutics with a rating of Buy and set a new price target of $25.00

    4/15/26 8:09:21 AM ET
    $KZIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Morgan Stanley resumed coverage on Spotify with a new price target

    Morgan Stanley resumed coverage of Spotify with a rating of Overweight and set a new price target of $630.00

    4/13/26 9:01:02 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    Byrna Technologies downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded Byrna Technologies from Buy to Hold and set a new price target of $7.50

    4/10/26 8:29:01 AM ET
    $BYRN
    Industrial Machinery/Components
    Miscellaneous

    $ACB
    $AGS
    $AIH
    $ARDX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $AGS
    $AIH
    $ARDX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Ettenberg Felecia

    3 - ARDELYX, INC. (0001437402) (Issuer)

    4/22/26 4:04:27 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Trabelsi Barak

    3 - SuperCom Ltd (0001291855) (Issuer)

    4/20/26 5:30:18 PM ET
    $SPCB
    Semiconductors
    Technology

    SEC Form 4 filed by Mckhann Chas

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    4/17/26 4:32:04 PM ET
    $COCH
    Industrial Specialties
    Health Care

    $ACB
    $AGS
    $AIH
    $ARDX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

    WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced an abstract, exploring the patient characteristics associated with irritable bowel syndrome with constipation (IBS-C) treatment patterns and their impact on gastrointestinal (GI) related healthcare resource utilization (HCRU), has been accepted as a poster presentation at the upcoming Digestive Disease Week Conference (DDW), to be held May 2-5, 2026, in Chicago. Information regarding DDW can be found here. Patient Factors Associated wi

    4/23/26 8:01:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University

    MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century's proprietary reduced nicotine content technology platform, which utilizes advanced plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The Company's reduced nicotine tobacco is the foun

    4/23/26 7:50:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $AGS
    $AIH
    $ARDX
    SEC Filings

    View All

    SEC Form DEFA14A filed by Outset Medical Inc.

    DEFA14A - Outset Medical, Inc. (0001484612) (Filer)

    4/24/26 4:15:03 PM ET
    $OM
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form DEF 14A filed by Outset Medical Inc.

    DEF 14A - Outset Medical, Inc. (0001484612) (Filer)

    4/24/26 4:06:06 PM ET
    $OM
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Envoy Medical, Inc. (0001840877) (Filer)

    4/21/26 4:25:40 PM ET
    $COCH
    Industrial Specialties
    Health Care

    $ACB
    $AGS
    $AIH
    $ARDX
    Leadership Updates

    Live Leadership Updates

    View All

    MediaCo Appoints Roberto Castro to Senior Vice President and Corporate Controller

    MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Roberto Castro to Senior Vice President and Corporate Controller. Mr. Castro brings 30 years of media and entertainment sector experience along with extensive financial management expertise to the company. He joins MediaCo following a nearly 24-year career at Spanish Broadcasting System (SBS), where he served in various senior finance roles, including Vice President of Finance since 2015. Prior to joining SBS, he spent over six years at DIRECTV Latin America, where he held the roles of Accounting & Consolidation Manager and Senior Auditor. Previously, he served as an auditor at Coopers & Lybrand, LLP. He holds an MPA in

    4/20/26 9:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

    WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company. "I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mik

    4/20/26 8:00:00 AM ET
    $ARDX
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Envoy Medical Appoints Chas McKhann to Board of Directors

    Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareholder Value Leading to over $3.4 Billion in Successful ExitsWhite Bear Lake, Minnesota--(Newsfile Corp. - April 16, 2026) - Envoy Medical®, Inc. (NASDAQ:COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced the appointment of Chas McKhann, a seasoned medical technology executive with documented success, to its Board of Directors.Mr. McKhann is a well-known and respected med tech leader with extensive experience creating and executing commercialization plans that have scaled into high-growth companies creating significant shareholder valu

    4/16/26 8:00:00 AM ET
    $COCH
    Industrial Specialties
    Health Care

    $ACB
    $AGS
    $AIH
    $ARDX
    Financials

    Live finance-specific insights

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026

    LOUISVILLE, Colo., April 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the first quarter ended March 31, 2026 after the close of trading on Monday, May 4. Biodesix management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. Listeners can register for the webcast via this link. Analysts who wish to participate in the question and answer session should access the live call by dialing (800) 715-9871 (domestic) or +1 (646) 307-1963 (international) and enter the passcode 2430172.

    4/20/26 6:00:00 AM ET
    $BDSX
    Medical Specialities
    Health Care

    Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026

    WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX) ("Ardelyx" or the "Company"), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Thursday, April 30, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2026. Webcast InformationA live webcast of the conference call and accompanying slides will be available in the "Events and Presentations" section under "News and Events" within the Investors section of the Company'

    4/16/26 8:01:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $AGS
    $AIH
    $ARDX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13D/A filed by HWH International Inc.

    SC 13D/A - HWH International Inc. (0001897245) (Subject)

    11/26/24 7:34:11 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13D/A filed by HWH International Inc.

    SC 13D/A - HWH International Inc. (0001897245) (Subject)

    11/22/24 5:00:10 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care